Saif MW, Shi N, Zelt S. Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States. World J Gastroenterol 2009; 15(35): 4415-4422 [PMID: 19764093 DOI: 10.3748/wjg.15.4415]
Corresponding Author of This Article
Muhammad Wasif Saif, MD, Gastrointestinal Cancers Program, Yale Medical Oncology, 800 Howard Avenue, New Haven, CT 06519, United States. wasif.saif@yale.edu
Article-Type of This Article
Brief Articles
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/